Profile of selected cytokines in serum and in BAL-fluid in patients with cryptogenic organising pneumonia before and after 3 months of calrithromycin treatment

E. Radzikowska, E. Wiatr, A. Rozy, R. Langfort, P. Rudzinski, A. Jarzemska, J. Chorostowska (Warsaw, Poland)

Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Session: Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Session type: E-Communication Session
Number: 5230
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Radzikowska, E. Wiatr, A. Rozy, R. Langfort, P. Rudzinski, A. Jarzemska, J. Chorostowska (Warsaw, Poland). Profile of selected cytokines in serum and in BAL-fluid in patients with cryptogenic organising pneumonia before and after 3 months of calrithromycin treatment. Eur Respir J 2010; 36: Suppl. 54, 5230

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical analysis of 25 subjects with biopsy-proven cryptogenic organizing pneumonia
Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Year: 2007


Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

Serum levels of IL-6 in severe community-acquired pneumonia
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010

Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Levels of IL-8 and IL-10 in the serum of blood of patients with nosocomial pneumonia at the abdominal sepsis
Source: Eur Respir J 2005; 26: Suppl. 49, 189s
Year: 2005

The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006

Serum KL-6 level is increased in patients with pneumocystis pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 101s
Year: 2006

Clinical significance of serum CA 15-3 in patients with idiopathic interstitial pneumonias
Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties
Year: 2007


The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


Systemic cytokine response in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 37: 1431-1438
Year: 2011



Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia
Source: Eur Respir J 2008; 32: 726-732
Year: 2008



Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
Source: Eur Respir J 2002; 20: 990-995
Year: 2002



Local and systemic cytokine profiles in patients with non-severe and severe community-acquired pneumonia
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012

Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011

The non-responding pneumonia
Source: Annual Congress 2005 - Difficult infections in the respiratory patient
Year: 2005

Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006

Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003

An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


The discriminatory value of procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients presenting with community acquired pneumonia (CAP) due to pulmonary tuberculosis (PTB) compared with patients with pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004